Caption: Corporate Profile covers recent news from CEL-SCI Corporation. They announced that it has signed a co-development and profit sharing agreement with Ergomed Clinical Research Ltd. for CEL-SCI’s investigational immunotherapy drug Multikine (&ldqu
Credit: CEL-SCI Corporation